SCPH
Price:
$5.11
Market Cap:
$255.65M
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. sc...[Read more]
Industry
Biotechnology
IPO Date
2017-11-17
Stock Exchange
NASDAQ
Ticker
SCPH
According to scPharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.28. This represents a change of -10.30% compared to the average of -3.66 of the last 4 quarters.
The mean historical PE Ratio of scPharmaceuticals Inc. over the last ten years is -5.17. The current -3.28 PE Ratio has changed 6.24% with respect to the historical average. Over the past ten years (40 quarters), SCPH's PE Ratio was at its highest in in the September 2016 quarter at -0.41. The PE Ratio was at its lowest in in the September 2017 quarter at -11.31.
Average
-5.17
Median
-4.41
Minimum
-15.02
Maximum
-1.50
Discovering the peaks and valleys of scPharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.56%
Maximum Annual PE Ratio = -1.50
Minimum Annual Increase = -76.79%
Minimum Annual PE Ratio = -15.02
Year | PE Ratio | Change |
---|---|---|
2023 | -4.41 | -18.70% |
2022 | -5.42 | 20.33% |
2021 | -4.50 | 19.18% |
2020 | -3.78 | 23.53% |
2019 | -3.06 | 29.09% |
2018 | -2.37 | 57.56% |
2017 | -1.50 | -76.79% |
2016 | -6.48 | -56.85% |
The current PE Ratio of scPharmaceuticals Inc. (SCPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.78
5-year avg
-4.23
10-year avg
-5.17
scPharmaceuticals Inc.’s PE Ratio is less than Milestone Pharmaceuticals Inc. (-2.00), greater than Oncolytics Biotech Inc. (-3.53), less than Seres Therapeutics, Inc. (-0.89), less than aTyr Pharma, Inc. (-2.33), greater than DiaMedica Therapeutics Inc. (-7.71), less than Lyra Therapeutics, Inc. (-0.18), greater than Centessa Pharmaceuticals plc (-9.93), less than Scopus BioPharma Inc. (0), less than Monopar Therapeutics Inc. (-0.00), less than Pasithea Therapeutics Corp. (-1.18), less than Iovance Biotherapeutics, Inc. (-0.27), greater than null (-6.48),
Company | PE Ratio | Market cap |
---|---|---|
-2.00 | $77.77M | |
-3.53 | $73.75M | |
-0.89 | $145.36M | |
-2.33 | $131.12M | |
-7.71 | $172.27M | |
-0.18 | $17.85M | |
-9.93 | $1.62B | |
0 | $12.63K | |
-0.00 | $8.41M | |
-1.18 | $4.37M | |
-0.27 | $3.04B | |
-6.48 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like scPharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like scPharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is scPharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for scPharmaceuticals Inc. (SCPH)?
What is the highest PE Ratio for scPharmaceuticals Inc. (SCPH)?
What is the 3-year average PE Ratio for scPharmaceuticals Inc. (SCPH)?
What is the 5-year average PE Ratio for scPharmaceuticals Inc. (SCPH)?
How does the current PE Ratio for scPharmaceuticals Inc. (SCPH) compare to its historical average?